相关实验视频
Updated: Jun 18, 2025

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
Published on: June 14, 2021
氧化增强了帕克利塔塞尔在体外对人类乳腺癌SKBR3细胞的抗瘤作用
Fangfang Liu1, Hongmei Yuan1, Chenyang Xu1
1Department of Anesthesiology, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, China.
与帕克利塔塞尔 (PTX) 结合的氧化 (OXY) 显示出对乳腺癌细胞的协同作用. 这种组合增强了亡并抑制了扩散,迁移和入侵,这表明了潜在的新乳腺癌治疗策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 氧化 (OXY) 和帕克利塔塞尔 (PTX) 对乳腺癌的联合作用在很大程度上仍未被描述.
- 了解这些相互作用对于开发新的治疗策略至关重要.
研究的目的:
- 研究OXY和PTX对人类乳腺癌SKBR3细胞增殖,亡和迁移的影响.
- 阐明它们联合作用的潜在分子机制.
主要方法:
- 进行了细胞活力,殖民地形成,亡,迁移和入侵试验.
- 蛋白质表达和自体分别使用西式斑点和传输电子显微镜进行了分析.
主要成果:
- 仅OXY就抑制了SKBR3细胞活力,殖民地形成,迁移和入侵.
- 在SKBR3细胞中,OXY显著诱导了亡和自.
- OXY和PTX显示出对增殖和增强亡的协同抑制,降低N-cadherin,Beclin-1,LC3-II,p-Akt和p-mTOR的调节,同时提高E-cadherin的调节.
结论:
- 在实验室中,OXY增强了PTX对乳腺癌细胞的抗瘤作用.
- OXY和PTX的组合为乳腺癌治疗提供了一个有前途的治疗策略.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
08:29Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
相关概念视频
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...